Published in AIDS Weekly, February 26th, 1996
The product, developed and produced by the Coulter Corporation, is intended for use by blood and plasma collection centers nationwide to screen blood samples for the presence of HIV-1. Ortho Diagnostic Systems Inc., will market the product on an exclusive basis after FDA approval.
Studies show that there is a window period of about 25 days between the time a person...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.